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Psychometric Testing of the Life Changes in Epilepsy Scale 
Introduction 
Epilepsy is a leading chronic neurological condition in the United States. More than 2 
million American adults currently live with a diagnosis of epilepsy, and 150,000 more receive an 
epilepsy diagnosis each year. Epilepsy is a chronic disease that results from abnormal surges in 
electrical signals in the brain, causing recurring seizures. There are numerous causes of 
epilepsy, though in most cases the cause is unknown. For most people, there is no cure for 
epilepsy, and thus the disorder must be managed over a lifetime. Adult-onset epilepsy is 
common, with those aged 18 and older having the highest incidence of new-onset epilepsy in 
the United States (Epilepsy Foundation, 2015). Adults with epilepsy report a lower quality of life 
(QoL) and perceived health status than those without the disorder, and commonly experience 
negative life changes such as unemployment, poor social relationships, and poor physical 
functioning (Unger & Buelow, 2009; Zhao et al., 2012; Miller, Bakas, & Buelow, 2013).  
The Institute of Medicine, in its 2012 report on epilepsy, highlighted the need for 
behavioral interventions to improve epilepsy-related outcomes in persons of all ages. The 
development and testing of such self-management interventions for adults with epilepsy is 
impeded by the lack of a sensitive, patient-centered outcome measure. Several epilepsy-
specific QoL measures have been published in the literature, and many have evidence of 
satisfactory reliability and validity. However, these measures lack sensitivity, as they fail to 
measure perceived changes in QoL caused by epilepsy; existing measures are not designed to 
detect a person’s perceived life changes experienced as a result of having epilepsy. Recent 
patient-centered outcomes research involving persons with adult-onset epilepsy has revealed 
that adult-onset epilepsy causes undesired life changes, including alterations in social 
functioning, somatic health, and well-being (Miller, 2014). A tool that can be easily used in 
clinical practice to measure these life changes resulting from having epilepsy is needed to 
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prioritize and guide the development of interventions for adults with epilepsy, and to provide a 
more comprehensive and sensitive assessment of outcomes for adults with epilepsy. 
The purpose of this study was to psychometrically test a pilot version of the Life 
Changes in Epilepsy Scale (LCES), which was designed to measure adults’ perceived life 
changes since being diagnosed with epilepsy. Evidence of the content and face validity of the 
LCES has been reported elsewhere (Miller et al., 2015). Specific aims of the current study were: 
Aim 1: Evaluate the properties of 35 items comprising the Life Changes in Epilepsy 
Scale - Pilot (LCES-P), a preliminary 35-item scale to measure life changes resulting from 
epilepsy.  
Aim 2: Use item analysis results to optimize the scale in terms of subject burden and 
interpretability. 
Aim 3: Evaluate construct and criterion-related validity of the optimized LCES (LCES-O). 
Background 
Considerable evidence exists to suggest that epilepsy is a life-altering chronic disease. 
Adults with epilepsy report unpleasant emotional and physical symptoms, and also have a 
higher incidence of psychiatric co-morbidities when compared to their epilepsy-free 
counterparts. Adults with epilepsy also suffer decrements in social relationships and physical 
functioning, as well as high rates of unemployment (Epilepsy Foundation, 2015). 
Review of existing quality of life measures. Table 1 provides a summary of six QoL 
scales that are commonly used as outcome measures in the epilepsy population (Davies et al., 
2009). These measures include the Medical Outcomes SF-36 Survey (SF-36), Personal Impact 
of Epilepsy Scale, The Quality of Life Index-Epilepsy (QoLI-epilepsy), the Quality of Life in 
Epilepsy (10-, 31-, and 89-item versions) (QoLIE-10, 31, 89), and the Patient Reported 
Outcomes Information System (PROMIS) Impact of Illness Scales. The SF-36 is a global QoL 
measure with ample evidence of reliability and validity in multiple chronic disease populations, 
including epilepsy (Ware & Sherbourne, 1992). Though it is the most commonly used general 
QoL measure used in the epilepsy population, the SF-36 does not measure QoL in the context 
of epilepsy. The SF-36 was administered to 3,520 persons with epilepsy and, though it 
demonstrated evidence of reliability and validity, the scale had significant ceiling effects in all 
subscales (Davies et al., 2009). The SF-36 also does not address the need for a measure that 
is sensitive to change. 
The Personal Impact of Epilepsy Scale (PIES) (Fisher et al., 2015) is epilepsy-specific 
and appropriately patient-centered. However, the PIES has demonstrated evidence of reliability 
and validity in a potentially inadequate sample (50 participants completed the 152-item scale, 
and 40 participants completed the follow-up 40-item scale). It is also unclear if the PIES asks 
respondents to answer items in relation to how aspects of their lives have changed due to 
epilepsy (Fisher et al., 2015). The QoLI-epilepsy scale and all versions of the QoLIE have 
evidence of reliability and validity, and are epilepsy-specific. However, these scales do not 
measure perceived changes in health-related QoL (Cramer et al., 1998), and thus do not 
remedy the gap in measurement tools for this population described earlier. The Patient 
Reported Outcomes Measurement Information System (PROMIS) is a system of patient-
reported measures for physical, mental, and social well-being. The PROMIS has demonstrated 
evidence of reliability and validity in a variety of chronic disease populations. This system 
includes two instruments that measure the impact of a chronic condition (illness impact negative 
or positive) (PROMIS, 2011). This system has not, however, been used in a population of those 
with epilepsy, and the illness impact scales lack epilepsy-specific items. Epilepsy is a complex 
condition and is characterized by its unique effects on those who suffer from it. Thus, an 
epilepsy-specific measure is needed to adequately capture life changes due to epilepsy. 
Conceptual framework. We endeavored to develop an epilepsy-specific, patient-
centered, and theory-based outcome measure for adults with epilepsy. Specifically, we sought 
to render this measure capable of detecting perceived life changes that have occurred since 
epilepsy onset. The Life Changes in Epilepsy Scale, Pilot version (LCES-P) was thus developed 
based on existing epilepsy- and chronic disease self-management literature and portions of 
Lazarus and Folkman’s Theory of Stress, Coping, and Adaptation (1984). In their theory, 
Lazarus and Folkman posit that three adaptational outcomes—social functioning, somatic 
health, and subjective well-being—are met to varying degrees as a result of the coping process. 
Based on qualitative research in which adults with epilepsy identified epilepsy-related outcomes 
of importance to them, we submit that the adaptational outcomes included in Lazarus and 
Folkman’s theory are representative of patient-centered outcomes in adults with epilepsy. The 
LCES-P was developed based on the conceptual framework depicted in Figure 1. The 
framework is based on a review of the literature and the Theory of Stress, Coping, and 
Adaptation. Adults with epilepsy experience symptoms due to the disease. In the framework, 
epilepsy variables (seizure characteristics and behaviors) influence the occurrence of 
symptoms. These symptoms are proposed to lead to undesirable life changes due to epilepsy 
(LCES-P) among other more global adaptational outcomes (general health). 
Procedures for Instrument Development 
Details regarding the development and content and face validity testing of the LCES-P 
have been reported elsewhere (Miller et al., 2015). Initially, we generated 41 epilepsy-specific 
items that were designed to measure life changes in the areas of social functioning, somatic 
health, and subjective well-being since epilepsy onset. These items were developed based on 
qualitative data collected from adults with epilepsy (Unger & Buelow, 2009; Miller, 2014), as well 
as a review of the epilepsy literature and in congruence with the underlying theoretical 
framework discussed earlier. After testing the content and face validity of the LCES, the number 
of items on the scale was reduced to 35, plus an additional criterion item (item number 36). 
Description, Administration, and Scoring of the LCES-P 
A sample of the LCES-P is included in Figure 2. The response format for the LCES was 
adapted from Bakas and colleagues’ (Bakas et al., 2006) Bakas Caregiver Outcomes Scale 
(BCOS), on which responses are measured via a 7-point Likert scale (Changed for the worst=-3 
to Changed for the best=+3). The -3 to +3 ratings are recoded to 1 to 7 so that positive numbers 
can be used for analysis. Total LCES-P scores can range from 35 to 245, with higher scores 
indicating more positive outcomes. The LCES-P can be self-administered, or administered by a 
provider in person or via phone. The format of the LCES-P could also be easily adapted to an 
online format.  
Methods 
Recruitment 
Following approval of the study by the university and hospital Institutional Review 
Boards, 174 adults with epilepsy were recruited to the study. Inclusion criteria were: 1) age 18 
years or older; 2) diagnosis of epilepsy; 3) prescription of at least one anti-epileptic drug; 4) able 
to speak and read English; 5) access to a telephone; 6) community-dwelling; 7) diagnosed with 
epilepsy at age 16 or older; and 8) cognitively intact as measured by the 6-item cognitive 
screener. Three methods of recruitment were utilized. The primary method of recruitment 
involved at-a-distance techniques as described by Miller and colleagues (2013). Two physicians 
(one epileptologist, one neurologist) and their staff identified patients who met the initial 
inclusion criteria of being age 18 and older and diagnosed with epilepsy at age 16 or later; the 
physicians mailed letters to potential participants informing them of the study and that they 
would be contacted by a researcher via phone in the next 10 days. The letters also included a 
number for patients to call in the event they did not wish to be contacted regarding the study. 
Members of the research team contacted potential participants by phone; those interested were 
screened against inclusion criteria prior to being admitted to the study. A total of 153 
participants were recruited using this method. A secondary method of recruitment involved an 
epileptologist providing patients with study materials during clinic visits. Ten participants were 
recruited using this method. The final method of recruitment was via Epilepsy Foundation 
newsletters and online message boards. Potential participants recruited via this method 
contacted the researcher via contact information provided. Participants received two copies of 
the informed consent statement via mail; participants signed one copy of the consent and 
returned it to the researcher via mail, and the other copy was kept by participants for their 
records. Eleven participants were recruited using this method. 
Procedure and Measures 
 As part of a parent study of which the current study is a sub-study, 11 measures were 
administered to participants by telephone (See Table 2). Participants were also asked to provide 
demographic information (See Table 3). Research assistants recorded participants’ responses 
on paper, and these answers were later entered into an electronic database and were double-
checked for accuracy. Data collection calls ranged in length from 23 to 90 minutes, with a mean 
of 42 minutes. Completion time of the LCES-P ranged from 5-21 minutes, with a mean time of 9 
minutes. Measures of interest in the current study included the LCES-P and the SF-36, as they 
were used to fulfill the aims of this sub-study.  
Data Analysis 
 Scale scoring, examination of missing value patterns, value distributions, and estimation 
of coefficient alpha were performed using SAS version 9.3. Factor analyses and testing 
construct validity were performed with Mplus version 7.11 (Muthen & Muthen, 2012). Mplus was 
chosen for factor and construct validity analyses due to its capability to (1) employ full 
information maximum likelihood (FIML), which uses all available data (that is, an observation is 
not summarily dropped if there are missing data); (2) appropriately accommodate the ordered 
category measurement level of the LCES-P items; (3) perform parallel analysis to provide data-
based guidance for identifying number of factors; and (4) utilize Bayesian analysis methods, 
which performs better with smaller samples and non-normal distributions than maximum 
likelihood methods (Gelman et al., 2004; Hayton, Allen, & Scarpell, 2004; Muthen & 
Asparouhov, 2012).  
 Aim 1 was addressed by exploring the factor structure, Cronbach’s alpha, and item-total 
correlations of the LCES-P. Ferketich’s criterion for an acceptable item-total correlation range 
(.30-.70) was used to identify items for potential removal (Ferketich, 1991). Parallel analysis 
(Allen & Scarpello, 2004) was used to identify the number of factors reflected in the LCES-P. 
Exploratory factor analysis, using the WLSMV estimator and an oblique geomin rotation, was 
used to test factor loadings for LCES-P items. Fit of the model was assessed by examining 
model fit χ2, Root Mean Square Error of Approximation (RMSEA), and the Cumulative Fit Index 
(CFI). Aim 2 was addressed by examining Cronbach’s Alpha and item-total correlations for the 
LCES-P. Aim 3 was addressed by (1) examining model fit for the measurement model of the 
optimized LCES scale (LCES-O) and (2) testing correlations between scores on the LCES-O, 
the SF-36 General Health subscale and LCES-P Item 36. Due to the ordered category scale of 
Item 36, a Bayes approach was used to estimate correlations among those three measures. 
Non-informative priors were used to start the estimation algorithm. Convergence and model fit 
were evaluated using trace and autocorrelation plots for the parameter estimates as well as the 
potential scale reduction and the posterior predictive p-value. Posterior credibility intervals (CI) 
for individual parameter estimates were evaluated for inclusion of a value of zero, which was 
interpreted as there being no substantive association.  
Results 
Sample and Measures 
One hundred seventy four participants completed the study. Sample characteristics are 
displayed in Table 3. The sample was predominantly female, married, White, and unemployed. 
The means, variances, and ranges for the LCES-P and SF-36GH are displayed in Table 4. 
LCES-P Psychometrics 
Total scale Cronbach’s Alpha, item means, standard deviations, item-total correlations, 
and Alpha if item removed are presented in Table 5. Item means ranged from 2.25 (my financial 
well-being) to 4.11 (my ability to achieve personal goals). There was satisfactory variability in 
relation to the means (SDs ranged from 1.03 to 1.53). Item means indicate that financial well-
being and experience of unpleasant symptoms were rated lowest by respondents, while 
relationships with immediate family members and ability to achieve personal goals were rated 
the highest.  
Item-total correlations ranged from 0.22-0.80. A total of 20 items with item-total 
correlations outside the acceptable 0.30 – 0.70 range were considered for deletion. 
Results of the exploratory factor analysis of the LCES-P appear in Tables 6 and 7. There 
were six missing data patterns: 169 observations had complete data, while 4 observations had 
missing data for a single item, and 1 observation had missing data for 2 items. Covariance 
coverage ranged from 100% to 98.9%, adequate for good performance of FIML estimation 
methods. Based on the parallel analysis (Table 6), an exploratory analysis extracting two factors 
was performed on the 35 items (Table 7). Fit of the 2-factor model was poor, based on the χ2, 
RMSEA, and CFI values. Only three items (LCES14, LCES15, and LCES17) loaded primarily 
on Factor 2, and there was a weak correlation between the two factors. 
LCES Optimization 
Based on the initial item analysis and exploratory analysis of the LCES-P, several items 
were considered for elimination, as was the possibility that the items represented a one-
dimensional construct. Of the 35 items, 21 had item-total correlations outside the 0.30 – 0.70 
range. Eighteen of those items were dropped, and three items (LCES24, LCES28, and 
LCES29) were retained due to their conceptual importance. The resulting 17-item optimized 
scale exhibited a good internal consistency (Cronbach’s Alpha = .92), and the one-factor model 
demonstrated adequate fit to the data (Table 8).  
Optimized LCES Scale Criterion-Related Validity 
Bayes-estimated correlations among LCES-O, SF-36 General Health, and LCES-P scales, along 
with the corresponding 99% credibility intervals are presented in Table 9. The model was consistent with 
the observed data, as evidenced by the model fit statistics. All correlations were greater than zero, as 
predicted by theory. Additionally, the strongest correlation was observed between the LCES-O and the 
LCES36 item, an epilepsy-specific criterion item, which asked participants to rate perceived changes in 
their lives overall since epilepsy onset. That observation is also consistent with theoretical expectations, 
given that the SF-36 General Health subscale is not specific to epilepsy-related health. 
Discussion 
Epilepsy is a life-changing disease that can lead to negative changes in social 
functioning, somatic health, and subjective well-being. There is a need for the development and 
testing of epilepsy self-management interventions designed to prevent or minimize these 
negative changes as much as possible (IOM, 2012). However, the lack of a sensitive outcome 
measure has impeded the development and testing of such interventions. The LCES-P was 
developed to address this need. 
Item analysis of the LCES-P revealed several important findings. There were few 
ceiling/floor effects, and missing data were minimal. The scale demonstrated good variability in 
relation to means. Examination of the item level of the LCES-P helps identify potential priority 
areas for interventions. Financial well-being and experience of unpleasant symptoms were rated 
lowest by respondents, suggesting that nurses and other healthcare professionals provide 
information about how to find financial assistance/manage finances and treatment of symptoms, 
including seeking appropriate referrals from epilepsy providers.  
LCES-P items were designed to measure changes in three specific areas: social 
functioning, somatic health, and subjective well-being. Thus, a three-dimensional scale was 
anticipated. However, the resulting unidimensionality of the LCES-P is not entirely surprising, 
given that the scale as a whole was designed to measure overall life changes. Bakas and 
colleagues (2006), in testing the psychometric properties of their caregiving outcomes scale 
aimed at measuring the same three concepts as the LCES-P also found a unidimensional scale. 
Focusing on the item level, the LCES might be used as an assessment tool to determine how to 
best address individual problems experienced by adults with epilepsy in the three different 
areas. At the scale level, the LCES could be used as a total score to measure overall outcomes 
in adults with epilepsy, as well as to serve as an important outcome measure in research. 
The initial, 35-item LCES-P was reduced to a 17-item scale following optimization. The 
resultant LCES-O is a brief measure with strong evidence of reliability and validity. The items 
removed from the LCES-P to form the LCES-O were deleted, based on item-to-total 
correlations, due to being irrelevant or redundant. The three items with item-to-total correlations 
outside the acceptable range that were retained were kept due to important conceptual 
relevancy. These items were related to respondents’ perceived changes in ability to lead a 
successful life, ability to take care of him/herself, and ability to live a normal life. Prior literature 
has indicated that these three specific areas are often negatively affected in persons with 
epilepsy (Unger & Buelow, 2009; Institute of Medicine, 2012; Miller, Bakas, & Buelow, 2013; 
Miller, 2015).    
FIML estimation revealed strong evidence of construct validity of the LCES-O, and 
Bayes-estimated correlations reveal evidence of criterion-related validity of the scale. These 
findings are in accord with the theoretical framework that guided development of this tool. 
The optimized version of the LCES is a brief measure with strong evidence of internal 
consistency reliability, as well as construct and criterion-related validity, and is suitable for use in 
both clinical and research settings. Clinically, the LCES can be used to provide a quick, 
epilepsy-focused QoL assessment in patient-centered areas. A total LCES score can supply the 
provider with an overall picture of how a person’s life is being affected by epilepsy; scores on 
individual items can guide nurses and other providers in choosing appropriate interventions for 
people living with epilepsy. Clinicians may find the LCES particularly helpful in assessing 
problematic areas in the lives of persons newly-diagnosed with epilepsy, as this population is at 
especially high risk of experiencing negative life changes (Unger & Buelow, 2009). As an 
outcome measure, the LCES is in accord with IOM recommendations for the measurement of 
patient-centered QoL, and could be easily used to measure changes in these outcomes due to 
intervention. 
Limitations 
 The cross-sectional nature of this study limits generalizability of findings. A longitudinal 
study is needed to assess the performance of the LCES over time. The lack of diversity in the 
sample is also limiting—participants were predominantly female and Caucasian, and most were 
from the Midwest. There is thus a need to test the LCES in more diverse contexts. Additionally, 
the LCES was not developed or tested with pediatric participants. It is possible that it could be 
adapted for use in younger teenagers who are capable of remembering—and thus assessing—
differences in their lives pre- and post-epilepsy. The LCES specifically targets persons 
diagnosed with epilepsy in early adulthood or later, and is less useful in persons who have had 
epilepsy since birth or very early in life. 
Conclusions 
 The optimized version of the LCES represents a unique, change-sensitive, patient-
centered outcome measure for people with epilepsy that demonstrates excellent evidence of 
reliability and validity and is not cumbersome for respondents. The LCES can thus be 
implemented into both clinical and research settings to measure life changes in adults with 
epilepsy. 
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Figure 2. Sample LCES Items and Response Scale 
Sample Item 
Response Scale 
Changed for the Worst Changed for the Best 
My happiness in general -3   -2    -1    0  +1    +2   +3 
My memory 3   -2   -1  0   +1  +2    +3 
The number of worries in my life 3   -2   -1  0   +1  +2    +3 
Instruction: For each possible change listed, circle the number indicating the degree of change you 
have experienced since being diagnosed with epilepsy. The numbers indicating the degree of change 
range from -3 (“Changed for the worst”) to +3 (“Changed for the best”). The number 0 means “Did 
not change.” 
Figure
Figure 1. Conceptual Framework 
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Table 1. Critique of Existing Instruments 
Instrument Epilepsy-
Specific 
Theory-Based Measures 
Perceived Changes 
Reliable and 
Valid 
SF-36 Health Survey  
Personal Impact of Epilepsy Scale  
QoLIE/QoLIE-31   
PROMIS Illness Impact Negative 
Scale 
  
PROMIS Illness Impact Positive Scale   
Table
Table 2. Instruments Administered to Participants 
Construct Measure Number of 
Items 
Scoring Reliability 
Adaptational Outcomes: 
Life changes 
Life Changes in 
Epilepsy Scale (LCES) 
35 ↑ TBD 
Adaptational Outcomes: 
General Health 
Medical Outcomes SF-
36 Health Survey 
General Health 
Subscale (SF-36GH) 
Used as criterion 
measure. 
36 ↑ .72-.94† 
.80* 
Adaptational Outcomes: 
Impact of illness 
PROMIS Impact Illness 
Positive Scale 
PROMIS Impact Illness 
Negative Scale 
8 
 
8 
↑ 
 
↓ 
.87-.89† 
 
.82-.85† 
Seizure characteristics Seizure Severity 
Questionnaire (SSQ)  
11 ↓ 0.74* 
 
Self-management 
behaviors 
Epilepsy Self-
Management Scale 
(ESMS)  
38 ↑ .81-.86† 
Self-management self-
efficacy 
Epilepsy Self-Efficacy 
Scale (ESES)  
33 ↑ .91-.93† 
Affective symptoms PROMIS Anxiety Scale 
PROMIS Depression 
Scale 
PROMIS Anger Scale 
Patient Health 
Questionnaire PHQ-9 
8 
8 
8 
9 
↓ 
↓ 
↓ 
↓ 
.82-.90† 
.89-.92† 
.86-.93† 
0.86-.89† 
0.84* 
Cognitive symptoms PROMIS Applied 
Cognition Concerns 
Scale 
PROMIS Applied 
Cognition Abilities 
Scale 
8 
 
8 
↓ 
 
↑ 
.86† 
 
.80† 
TBD = scale to be developed; ↓= lower scores indicate better outcomes; ↑ = higher scores indicate better outcomes; † = 
internal consistency reliability; * = test-retest reliability 
 
Table
Table 3. Sample Characteristics 
  Gender   
 Male Female Overall 
  N (%) N (%) N (%) 
Marital status    
 Married 24 (38.1) 50 (45.0) 74 (42.5) 
 Single 25 (39.7) 23 (20.7) 48 (27.6) 
 Other 14 (22.2) 38 (34.2) 52 (29.9) 
Type of Epilepsy    
 Complex Partial 10 (15.9) 23 (20.7) 33 (19.0) 
 Tonic Clonic 12 (19.0) 20 (18.0) 32 (18.4) 
 Both 12 (19.0) 19 (17.1) 31 (17.8) 
 Other 7 (11.1) 10 (9.0) 17 (9.8) 
 Unknown 22 (34.9) 39 (35.1) 61 (35.1) 
Income    
 Comfortable 15 (23.8) 44 (39.6) 59 (33.9) 
 Just enough to make ends meet 27 (42.9) 49 (44.1) 76 (43.7) 
 Do NOT have enough to make ends meet 21 (33.3) 18 (16.2) 39 (22.4) 
Employment Status    
 employed full-time 12 (19.0) 26 (23.4) 38 (21.8) 
 employed part-time 2 (3.2) 11 (9.9) 13 (7.5) 
 homemaker 0 (0.0) 10 (9.0) 10 (5.7) 
 retired 3 (4.8) 13 (11.7) 16 (9.2) 
 unemployed 23 (36.5) 18 (16.2) 41 (23.6) 
 Other (specify) 3 (4.8) 6 (5.4) 9 (5.2) 
 Disability 20 (31.7) 27 (24.3) 47 (27.0) 
Seizure Frequency    
 At least monthly 16 (25.4) 35 (31.5) 51 (29.3) 
 Bi-monthly 13 (20.6) 15 (13.5) 28 (16.1) 
 At most semi-annually 34 (54.0) 61 (55.0) 95 (54.6) 
Ethnicity    
 White 48 (78.7) 88 (83.8) 136 (81.9) 
 African American 10 (16.4) 12 (11.4) 22 (13.3) 
 Other 3 (4.9) 5 (4.8) 8 (4.8) 
    
 Median (IQR) Median (IQR) Median (IQR) 
Age (years) 48.0 (31.0, 56.0) 46.0 (33.0, 60.0) 47.0 (33.0, 57.0) 
Age at Diagnosis (years) 28.0 (21.0, 47.0) 30.0 (22.0, 41.0) 29.0 (22.0, 42.0) 
Time since Diagnosis (years) 6.0 (4.0, 14.0) 9.0 (4.0, 20.0) 8.0 (4.0, 18.0) 
Years of education 12.0 (12.0, 16.0) 14.0 (12.0, 16.0) 13.0 (12.0, 16.0) 
  
Table
Table 4. Descriptive Statistics of LCES-P and SF-36GH 
Measure Mean (SD) Range 
LCES-P 49.43(13.74) 18-97 
SF-36GH 49.31(23.12) 1-100 
Table
Table 5. Item analysis results – full 35 item scale using cases with complete data (N=169). 
Item Mean SD Item-Total 
Correlation 
Alpha if 
Item Deleted 
LCES01 2.93 1.28 0.72 0.962 
LCES02 2.74 1.29 0.71 0.962 
LCES03* 2.74 1.05 0.54 0.963 
LCES04* 2.25 1.13 0.66 0.962 
LCES05* 2.32 1.04 0.56 0.963 
LCES06 2.54 1.20 0.71 0.962 
LCES07 2.95 1.15 0.66 0.962 
LCES08* 2.95 1.09 0.68 0.962 
LCES09 2.65 1.20 0.69 0.962 
LCES10 3.07 1.07 0.74 0.962 
LCES11* 3.04 1.23 0.68 0.962 
LCES12 2.81 1.12 0.69 0.962 
LCES13* 2.54 1.16 0.68 0.962 
LCES14* 3.90 1.53 0.33 0.965 
LCES15 4.11 1.53 0.22 0.966 
LCES16 3.28 1.20 0.65 0.962 
LCES17* 3.66 1.37 0.47 0.964 
LCES18* 2.82 1.27 0.59 0.963 
LCES19 2.62 1.35 0.70 0.962 
LCES20 2.89 1.20 0.76 0.962 
LCES21 3.02 1.17 0.69 0.962 
LCES22* 2.72 1.16 0.68 0.962 
LCES23* 2.78 1.32 0.59 0.963 
LCES24* 2.92 1.32 0.77 0.962 
LCES25 2.85 1.24 0.72 0.962 
LCES26 2.71 1.11 0.76 0.962 
LCES27 3.06 1.03 0.57 0.963 
LCES28* 3.11 1.16 0.72 0.962 
LCES29* 2.69 1.25 0.80 0.961 
LCES30 3.02 1.17 0.69 0.962 
LCES31 3.25 1.16 0.67 0.962 
LCES32* 2.64 1.35 0.70 0.962 
LCES33* 3.50 1.26 0.54 0.963 
LCES34 2.69 1.26 0.77 0.962 
LCES35* 2.83 1.06 0.70 0.962 
Notes: 
Scale Alpha = 0.96 
* = Item retained in optimized 17-item scale 
Table
Table 6. Observed and Parallel Analysis-Derived Average Eigenvalues (first 6 out of 35) for LCSES-35 scale. 
Factor Sample Eigenvalue Parallel Average Eigenvalue 
1 16.35 1.97 
2 2.08 1.84 
3 1.68 1.74 
4 1.34 1.66 
5 1.16 1.59 
6 0.95 1.52 
Table
Table 7. Rotated factor loadings from exploratory analysis of LCSES-35. 
Item Factor 1 Rotated 
Loading 
Factor 2 Rotated 
Loading 
LCSES01 0.620* 0.331* 
LCSES02 0.709* 0.135* 
LCSES03 0.740* -0.224* 
LCSES04 0.718* 0.074 
LCSES05 0.546* 0.207* 
LCSES06 0.776* 0.008 
LCSES07 0.729* -0.014 
LCSES08 0.833* -0.095 
LCSES09 0.841* -0.052 
LCSES10 0.786* 0.042 
LCSES11 0.526* 0.432* 
LCSES12 0.702* 0.101 
LCSES13 0.689* 0.141* 
LCSES14 0.013 0.664* 
LCSES15 -0.143 0.688* 
LCSES16 0.506* 0.360* 
LCSES17 0.196* 0.599* 
LCSES18 0.756* -0.121* 
LCSES19 0.690* 0.221* 
LCSES20 0.574* 0.484* 
LCSES21 0.631* 0.238* 
LCSES22 0.733* 0.075 
LCSES23 0.506* 0.258* 
LCSES24 0.681* 0.343* 
LCSES25 0.661* 0.226* 
LCSES26 0.644* 0.305* 
LCSES27 0.633* 0.043 
LCSES28 0.868* -0.139* 
LCSES29 0.882* -0.050 
LCSES30 0.779* -0.044 
LCSES31 0.613* 0.215* 
LCSES32 0.930* -0.236* 
LCSES33 0.546* 0.065 
LCSES34 0.883* -0.084 
LCSES35 0.787* -0.016 
Loadings differing from 0 at p < .05 are indicated by *. 
Inter-Factor Correlation: 0.355 (p<.05) 
Model Fit: 
χ2 (DF=526)=1220.3, p<.001 
RMSEA = .087 (90% CI: 0.081  0.093) 
CFI = 0.947 
Table
Table 8. Model Fit and Factor Loadings for Optimized 17-Item 1-Factor Scale. 
Item Loading p 
LCSES03 0.627 <0.001 
LCSES04 0.724 <0.001 
LCSES05 0.630 <0.001 
LCSES08 0.780 <0.001 
LCSES11 0.694 <0.001 
LCSES13 0.745 <0.001 
LCSES14 0.316 <0.001 
LCSES17 0.424 <0.001 
LCSES18 0.717 <0.001 
LCSES22 0.775 <0.001 
LCSES23 0.576 <0.001 
LCSES24 0.796 <0.001 
LCSES28 0.788 <0.001 
LCSES29 0.879 <0.001 
LCSES32 0.812 <0.001 
LCSES33 0.579 <0.001 
LCSES35 0.761 <0.001 
Model Fit: 
χ2 (DF = 114) = 240.2, p <.001 
RMSEA = 0.08 (90% CI = 0.066 - 0.094) 
CFI = 0.976 
Table
Table 9. Bayes-estimated correlations (99% credibility interval) among optimized LCSES, 
SF-36 general health, and LCSES36 scales. 
Optimized 
LCES 
SF-36 
General 
Health 
LCES36 
Optimized 
LCSES 
1.0 
SF-36 
General 
Health 
0.479 
(0.10, 0.618) 
1.0 
LCSES36 0.789 
(0.698, 
0.854) 
0.338 
(0.153, 
0.502) 
1.0 
Model Fit: 
95% Confidence Interval for Observed-Replicated Chi Squared Values: -11.8, 12.8 
Posterior Predictive p value: 0.47 
Table
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